Motion Sickness
- Product NDC
- 59779-198
- 11-digit product format
- 597790198
- Labeler code
- 59779
- Product ID
- 59779-198_e72c2541-7d9f-435a-8ca7-c9d9fa116ea3
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Dimenhydrinate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- CVS Pharmacy
- Application
- M009
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 1992-12-01
- Substance
- DIMENHYDRINATE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 59779-198 | 59779-198-21 | D | Discontinued by firm | 2026-10-12 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 59779-198-21 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 59779-198-07 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 59779-198-21 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 59779-198-07 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 59779-198-21 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 59779-198-07 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 59779-198-21 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 59779-198-07 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 59779-198-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 59779-198-07 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 59779-198-21 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 59779-198-07 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 59779-198-21 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 59779-198-07 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 59779-198-21 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 59779-198-07 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 59779-198-21 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 59779-198-07 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 59779-198-21 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 59779-198-07 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 59779-198-21 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 59779-198-07 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 59779-198-21 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 59779-198-07 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Motion Sickness
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DIMENHYDRINATE | 50 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| JB937PER5C | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 198603 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 0998947c-cfba-497e-bf7a-9c7f8fff1764 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0e2e0f88-b076-afe1-4bdd-32bca4375bec | Product name | 3 | 20250127 |
| 3e48c9c4-918d-5d23-2f0b-d2398b06be54 | Product name | 1 | 20140508 |
| 865c72dd-0d94-daac-f728-ddd4ded2a79e | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59779-198-02 | Motion Sickness | 2 in 1 CARTON | TABLET | 2 | 16 | |
| 59779-198-02 | Motion Sickness | 6 in 1 BLISTER PACK | TABLET | 6 | 16 | |
| 59779-198-07 | Motion Sickness | 6 in 1 BLISTER PACK | TABLET | 6 | 16 | |
| 59779-198-07 | Motion Sickness | 6 in 1 CARTON | TABLET | 6 | 16 | |
| 59779-198-21 | Motion Sickness | 1 in 1 CARTON | TABLET | 1 | 16 | |
| 59779-198-21 | Motion Sickness | 16 in 1 VIAL | TABLET | 16 | 16 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Airmit Ace | DIMENHYDRINATE | Sato Pharmaceutical Co., Ltd. | a98d252d-4cfa-496a-ab2c-627f45f0d7d9 | 2023-12-01 | Warnings | M009 |
| Meclizine HCl | MECLIZINE HYDROCHLORIDE | BluePoint Laboratories | d9cae5a6-8d4b-bdaf-e053-2995a90a7d44 | 2023-11-17 | Warnings | M009 |
| ZenTrip Motion Sickness | MECLIZINE HYDROCHLORIDE | Sato Pharmaceutical Co., LTD | bd86c4c7-b6f0-e3e8-e053-2995a90a4454 | 2023-11-03 | Warnings | M009 |
| Travel-Ease | MECLIZINE HCL | Geri-Care Pharmaceutical Corp | e3c64eb9-4972-29d9-e053-2a95a90a2a8a | 2023-10-25 | Warnings | M009 |
| Gravol | DIMENHYDRINATE | Church & Dwight Co., Inc. | d95240bb-02f2-3226-e053-2995a90afacd | 2022-03-03 | Warnings | M009 |
| Allergy DyeFree | ALLERGY DYEFREE | Allegiant Health | 15736bb8-5a5b-489d-83ad-4cf34ec62956 | 2021-04-26 | Warnings | M009 |
| Motion Sickness Relief | DIMENHYDRINATE 50MG | Allegiant Health | 7b0aa993-f08f-4dff-a82d-f35b3ebe3cc1 | 2019-12-12 | Warnings | M009 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 198603 | dimenhyDRINATE 50 MG Oral Tablet | PSN | 0998947c-cfba-497e-bf7a-9c7f8fff1764 | 16 |
| 198603 | dimenhydrinate 50 MG Oral Tablet | SCD | 0998947c-cfba-497e-bf7a-9c7f8fff1764 | 16 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 59779-198-02 | 59779019802 | 2 BLISTER PACK in 1 CARTON (59779-198-02) / 6 TABLET in 1 BLISTER PACK | 2 blister pack | 1992-12-01 | No | No | Current | |
| 59779-198-07 | 59779019807 | 6 BLISTER PACK in 1 CARTON (59779-198-07) / 6 TABLET in 1 BLISTER PACK | 6 blister pack | 1992-12-01 | 0000-00-00 | No | No | Current |
| 59779-198-21 | 59779019821 | 1 in 1 CARTON | Historical |